BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 15, 2019
View Archived Issues
LIDDS begins phase I study of intratumoral NanoZolid combined with docetaxel for solid tumors
Read More
Identification of a novel immunotherapy target to treat myeloid blood cancers
Read More
Analysis identifies key bacterial virulence gene
Read More
DermBiont initiates phase II study of DBI-001 for the treatment of athlete's foot
Read More
Veverimer phase III results for metabolic acidosis associated with chronic kidney disease
Read More
ABBV-151 enters first-in-human study
Read More
Scholar Rock names TGF-beta1 activation inhibitor for further development
Read More
Targeting AhR for treating age-related macular degeneration proven useful
Read More
Bayer presents CHICO phase III results for nifurtimox in pediatric Chagas disease
Read More
FP-101 relieves hot flashes in menopausal women and women taking tamoxifen
Read More
ImmunogenX initiates phase II study of latiglutenase for celiac disease
Read More
Fujian Institute of Research on the Structure of Matter presents interferon modulators
Read More
Jiangsu Chia Tai Tianqing Pharmaceutical Group and others patent TRK inhibitors
Read More
Asceneuron discovers N-acetyl-beta-D-glucosaminidase inhibitors
Read More
Acesion Pharma identifies new SK (Ca) 2.3 channel blockers
Read More
New PIK3C3 and authophagy inhibitors synthesized at Sprint Bioscience
Read More
Phase I/II study planned for ACT-107 after first-in-human results show safety
Read More
Sutro initiates phase I study of STRO-002 in ovarian and endometrial cancers
Read More
Spectrum withdraws BLA for Rolontis with plans to resubmit
Read More
BCL9 targeting impacts intestinal neoplasia pathogenesis
Read More
Recreating lineage-specific cardiac cells from iPSCs
Read More
Antibodies to mosquito saliva offer Zika protection
Read More
Protein kinase C inhibitor LXS-196 studied in uveal melanoma patients
Read More